# Career Enhancement Program

> **NIH NIH P50** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2021 · $69,630

## Abstract

PROJECT SUMMARY (Career Enhancement Program) 
The goal of the Career Enhancement Program (CEP) is to provide training and guidance for academic 
physician-scientists, clinician-investigators, and laboratory-based scientists who wish to dedicate their career 
and research efforts to leukemia translational research. To achieve this goal, the CEP will pursue the following 
specific aims: 
1. Recruit, train, and mentor physicians, scientists, and senior postdoctoral fellows to become 
 excellent leukemia investigators focused on leukemia translational research. 
2. Educate awardees in all the basic principles of cancer and leukemia biology, including molecular, cellular 
 and systems biology, drug development, pharmacokinetic and pharmacodynamics studies, and basic 
 principles of biostatistics and bioinformatics. 
3. Provide a firm foundation for awardees in the specific area of leukemia translational and early clinical 
research. 
These objectives will be achieved through strong mentorship in which awardees will be instructed in the 
principles of clinical, basic, and translational leukemia research. Specific areas of education will include 
scientific and clinical methods, biomedical ethics, statistical design and analysis, bioinformatics, biology, 
biochemistry, genetics, epidemiology, and other areas relevant to individual projects. Mentorship will include 
laboratory-based investigators, clinical-translational investigators, biostatisticians, bioinformaticians and 
epidemiologists. Mentors from within the Leukemia SPORE and the other 1,500 faculty members at the MD 
Anderson Cancer Center, Graduate School of Biomedical Sciences, Fox Chase Cancer Center and from the 
University of Texas in Houston, will provide the expertise required for the development of strong, productive 
translational research skills. 
Since its inception in 2003, the CEP has funded 54 awards given to 36 recipients, including 14 women and 14 
minorities, who have gained skills and expertise in designing and conducting clinical translational-based 
studies in leukemia, including incorporating laboratory-based studies in clinical trials and, conversely, 
transforming critical clinical observations into meaningful laboratory investigations. The majority have 
continued independent academic careers in leukemia or cancer research. Thus, this program has contributed 
to the career development of talented young leukemia investigators to hasten the development of effective 
new therapeutic strategies against leukemia.

## Key facts

- **NIH application ID:** 10247510
- **Project number:** 5P50CA100632-19
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** Marina Y Konopleva
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $69,630
- **Award type:** 5
- **Project period:** 2003-08-05 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10247510

## Citation

> US National Institutes of Health, RePORTER application 10247510, Career Enhancement Program (5P50CA100632-19). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10247510. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*